Catalyst Pharmaceuticals, Inc. (CPRX)
22.68
-0.48
(-2.07%)
USD |
NASDAQ |
Dec 09, 13:02
Catalyst Pharmaceuticals Profit Margin (Quarterly): 35.57% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Collegium Pharmaceutical, Inc. | 15.05% |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Amicus Therapeutics, Inc. | 10.24% |
| Rigel Pharmaceuticals, Inc. | 40.17% |
| United Therapeutics Corp. | 42.36% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 27.48% |
| Return on Assets | 23.86% |
| Return on Invested Capital | 27.37% |
| Gross Profit Margin (Quarterly) | 78.44% |
| Operating Margin (Quarterly) | 44.66% |
| Return on Net Operating Assets | 82.33% |